Last reviewed · How we verify

NCT04025489

Vitamin D Supplementation on Surrogate Markers of Ageing, Ageing Genes, Glycemic and Metabolic Markers in North India

Status unknown NA Last updated 15 June 2023
What this trial tests

NA trial testing Randomized control trial of vitamin D supplementation in Vitamin D Supplementation in 200 participants. Status unknown.

Timeline
1 March 2020
Primary endpoint
28 February 2024
30 March 2024

Quick facts

Lead sponsorDiabetes Foundation, India
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment200
Start date1 March 2020
Primary completion28 February 2024
Estimated completion30 March 2024
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

Diabetes Foundation, India

Who can join

Adults 20 to 60, any sex, with Vitamin D Supplementation or PreDiabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prediabetes is a substantial problem in India not only because it itself can be associated with morbidities such as coronary artery disease but also because it is a point of important for prevention of diabetes. It is not clear if apparent accelerated aging in Indian population associated with heightened tendency for prediabetes, metabolic syndrome, atherosclerosis and dys-metabolic state etc. could, besides lifestyle factors, be related to vitamin D deficiency, or ageing-related genes, or interaction between the two. This study is based on the assumption that the supplementation of vitamin d could lead to reversal to normal glucose regulation and may slow aging process in individuals with pre-diabetes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Diabetes Foundation, India trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04025489.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing